SequelSEC

Hypha Labs, Inc. FUNI

Services-Testing Laboratories · CIK 0001502966 · Fiscal year ends 0930

AnnualQuarterlyTTM
Revenue
$726.76K
Fiscal year ended 2022-12-31
Operating income
-$107.34K
Fiscal year ended 2022-12-31
Free cash flow
Unavailable
Fiscal year ended 2022-12-31

Hypha Labs, Inc. (FUNI) reported revenue of $726.76K and net income of -$240.33K for the fiscal year ended 2022-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Hypha Labs, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Testing Laboratories.

Income

Hypha Labs, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
Revenue$726.76K$712.94K$682.66K$604.74K$699.58K$606.24K$764.02K$633.16K$500.38K$603.26K
Cost of revenue$422.84K$401.04K$414.30K$396.03K$422.60K$398.86K$551.98K$416.92K$420.88K$528.33K
Gross profit$303.92K$311.90K$268.37K$208.70K$276.98K$207.38K$212.04K$216.24K$79.50K$74.93K
Operating income-$107.34K-$408.20K-$109.91K-$302.46K-$217.59K-$280.72K-$146.08K$2.62K-$348.26K-$914.37K
Net income-$240.33K-$829.19K-$576.73K-$373.60K-$277.60K-$136.85K-$177.21K$18.20K-$390.64K-$959.23K
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 82.22MUnavailableshares 75.15Mshares 74.02MUnavailableUnavailableshares 68.48Mshares 114.70MUnavailableUnavailable
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPS$0.00Unavailable$-0.01$0.00UnavailableUnavailableUnavailable$0.00UnavailableUnavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$39.52K$377.92K$35.71K$42.48K$240.96K$219.05K$278.08K$211.96K$225.05K$359.77K
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Hypha Labs, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
Cash & equivalentsUnavailable$56.17K$225.23K$82.77K$90.30K$295.93K$72.81K$113.71K$79.07K$82.75K
Total assets$1.18M$1.34M$1.94M$2.37M$2.12M$1.89M$1.50M$1.57M$1.56M$1.79M
Current assets$508.25K$562.10K$1.11M$1.47M$1.14M$826.86K$409.24K$384.11K$273.23K$397.24K
Total liabilities$3.73M$3.75M$3.96M$3.82M$3.31M$2.94M$2.68M$2.68M$2.86M$2.88M
Current liabilities$1.97M$2.95M$3.30M$3.07M$2.46M$2.01M$827.03K$788.28K$846.13K$772.79K
Total equity incl. NCI-$2.88M-$2.74M-$2.35M-$1.79M-$1.52M-$1.05M-$1.18M-$1.11M-$1.31M-$1.09M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$301.87K$335.08K$245.10K$259.27K$330.40K$214.90K$193.81K$210.73K$130.26K$242.14K
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$592.62K
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$571.12K$200.56K$487.08K$419.50K$368.03K$370.98K$340.49K$329.31K$460.09K$387.95K

Cash flow

Hypha Labs, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
Operating cash flow$17.23K-$15.87K$21.37K-$13.13K-$177.16K$3.13K-$44.49K-$30.91K-$63.69K-$56.67K
Capital expenditures$2.67K$13.48K$0$1.76K$2.48K$55.00K$0UnavailableUnavailable$0
Investing cash flow$97.33K-$13.48K$130.97K-$369.39K-$408.48K-$285.00K$0UnavailableUnavailable$0
Financing cash flow-$14.90K-$139.72K-$9.88K$374.98K$380.01K$505.00K$3.60K$66.75K$60.02K$12.56K
Net change in cash$99.66K-$169.06K$142.46K-$7.54K-$205.63K$223.12K-$40.90K$34.64K-$3.68K-$44.11K
Stock-based compensation$8.31K$368.51K$8.31K$103.46K$85.96K$165.76K$107.14K$86.92K$44.06KUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$35.76K$34.19K$52.90K$58.59K$58.47K$58.47K$74.45K$75.94K$83.26K$81.18K

Derived

Hypha Labs, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
Free cash flowUnavailableUnavailableUnavailableUnavailable-$179.64K-$51.87K-$44.49KUnavailableUnavailable-$56.67K
Gross margin41.8%43.7%39.3%34.5%39.6%34.2%27.8%34.2%15.9%12.4%
Operating marginUnavailableUnavailableUnavailableUnavailable-31.1%-46.3%-19.1%0.4%-69.6%-151.6%
FCF marginUnavailableUnavailableUnavailableUnavailable-25.7%-8.6%-5.8%UnavailableUnavailable-9.4%
SBC / revenueUnavailableUnavailableUnavailableUnavailable12.3%27.3%14.0%13.7%8.8%Unavailable
Current ratio0.26x0.19x0.34x0.48x0.46x0.41x0.49x0.49x0.32x0.51x
Revenue YoY growth3.9%17.6%-10.6%-4.5%39.8%0.5%87.6%-16.1%-38.1%-0.5%
Net marginUnavailableUnavailableUnavailableUnavailableUnavailable-22.6%-23.2%UnavailableUnavailable-159.0%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue0.4%1.9%0.0%0.3%0.4%9.1%0.0%UnavailableUnavailable0.0%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open FUNI in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-Q · Filed 2026-02-17View SEC filing
10-K · Filed 2026-01-15View SEC filing
10-Q · Filed 2025-08-21View SEC filing
10-Q · Filed 2025-06-13View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.